Researcher Funding For Tuberculosis Medication Research Is Awarded Twice
Researcher Funding For Tuberculosis Medication Research Is Awarded Twice The Bill & Melinda Gates Foundation has awarded two grants totaling $6.8 million to academics at Weill Cornell Medicine and the TB treatment Accelerator to examine tuberculosis (TB) treatment development. Two major roadblocks in tuberculosis drug development will be accelerated by this effort: discovering novel lead chemicals and new therapeutic targets within the bacteria. Chest pain, fever, and cough are symptoms of Mycobacterium tuberculosis (Mtb), a pathogen that multiplies in the lungs after infection. TB is still one of the most deadly infectious illnesses, despite its high contagiousness. Worldwide, 10.6 million people got the illness last year, and the World Health Organisation estimates that 1.3 million people died as a result. Taking many antibiotics for up to nine months is necessary for Tuberculosis treatment. “We could treat Tuberculosis much better in the regions where the disease takes its bigge...